Serum BAFF levels were determined in 10 of 25 NASH patients, 16 of 22 CLD-C patients and 5 cases of NHCs to investigate the relationship between autoimmune response and insulin resistance. Here, TNFSF13B is linked to metabolic dysfunction-associated steatohepatitis.